About Us

Corporate Profile

Name MicroBiopharm Japan Co., Ltd.
Date of Establishment July 1st, 2011
President & CEO Atsushi Shiota
Total Employees 369 (As of April 1st, 2024)
Head Office 1-3-1 Kyobashi, Chuo-ku, Tokyo, 104-0031 JAPAN
Tel.+81-3-6265-1761  Fax.+81-3-6265-1768
Access

History

1941 Started the production of Acetone and Butanol by fermentation at Showa Nosan Kako Co., Ltd. (currently Mercian Corporation) Yatsushiro plant (Business started)
1966 Started the production of Kasugamycin
1979 Started the production of RINGDEX (Cyclodextrin)
1981 Started the production of the injectable Aclarubicin
1988 Started the production of Daunorubicin
Started the production of injectable Pirarubicin
1989 Started the production of Doxorubicin
1994 Started the production of Calcitriol
2003 Completed construction of New Research and Development Building in Iwata plant (Iwata City, Shizuoka Prefecture)
2007 Started the production of Epirubicin
2010 Started the production of 25-Hydroxy vitamin D3
2011 MicroBiopharm Japan Co., Ltd. was founded and we started the business by the succession of the Pharmaceuticals & Chemicals Division of Mercian Corporation on July 1st (Head Office: Nihonbashi Honcho, Chuo-ku, Tokyo).
2012 Started the production of cis-5-Hydroxy-L-Pipecolinic acid
2014 Head office moved to Kyobashi, Chouo-ku, Tokyo (current address)
2016 Operation start up at Kiyosu plant in Aichi, acquired from Astellas Pharma Inc.
Completed construction of New Manufacturing Building in Yatsushiro plant (Yatsushiro City, Kumamoto Prefecture)
2017 Some functions of the Research and Development Division were transferred to the Kiyosu plant (Kiyosu City, Aichi Prefecture)
2018 Completed construction of New Manufacturing Building in Iwata plant (Iwata City, Shizuoka Prefecture)
2019 Completed construction of New Manufacturing Building in Kiyosu plant (Kiyosu City, Aichi Prefecture)
2020 Completed construction of New Manufacturing Building in Yatsushiro plant (Yatsushiro City, Kumamoto Prefecture)
2021 Investment funds managed by T Capital Partners Co., Ltd. became our shareholder on July 1st.